Treatment of IPF without nintedanib or pirfenidone

What treatment would you recommend in a patient with idiopathic pulmonary fibrosis who cannot be treated with nintedanib or pirfenidone?

Luca Richeldi: Of course it is a problem because the only two drugs that have been shown to be safe and effective are pirfenidone and nintedanib. The current guidelines also provide conditional recommendations, based on low-quality evidence, for antacid medications. So according to the current guidelines, that is an option.